- cafead   Jan 29, 2024 at 11:52: AM
via Roche has waved goodbye to one of its KRAS prospects, terminating an alliance with Hookipa Pharma 15 months after betting $25 million on its novel approach to the oncogene. Shortly after receiving the news, Hookipa decided to lay off 30% of its employees and focus on a slimmed-down list of candidates.
article source
article source